Literature DB >> 2476567

Identification of a doubly spliced viral transcript joining the separated domains for putative protease and reverse transcriptase of hepatitis B virus.

P J Chen1, C R Chen, J L Sung, D S Chen.   

Abstract

Hepatitis B virus (HBV), like retroviruses, replicates through reverse transcription. However, the identity and mechanism for the synthesis of HBV reverse transcriptase remain unknown. The open reading frame (ORF) for HBV putative reverse transcriptase (pol), as a consequence of overlapping with the whole ORF of envelope proteins (hepatitis B surface antigens), includes a hypervariable region at the N terminus. Thus, compared with retroviruses, it is unlikely that HBV reverse transcriptase is translated from complete pol ORF in the full-length pregenomic RNA. We have now detected in infected human livers a novel doubly spliced RNA in which one splicing event removed the hypervariable region of the pol gene but retained the conserved region homologous to retroviral reverse transcriptase. The other splicing event deleted the central region of hepatitis B core antigen and thus brought the protease domain which is important for maturation of reverse transcriptase close to that of pol. For this sequence organization, the spliced RNA as the possible template for the synthesis of HBV reverse transcriptase is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476567      PMCID: PMC251030     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Analysis of hepatitis B virus transcripts in infected human livers.

Authors:  T S Su; W Y Lui; L H Lin; S H Han; F K P'eng
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

2.  Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

Authors:  C Sureau; J L Romet-Lemonne; J I Mullins; M Essex
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

3.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

4.  Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.

Authors:  A Fujiyama; A Miyanohara; C Nozaki; T Yoneyama; N Ohtomo; K Matsubara
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

5.  Speculations on RNA splicing.

Authors:  P A Sharp
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

6.  Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus.

Authors:  H Toh; H Hayashida; T Miyata
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

7.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

8.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

9.  The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw.

Authors:  Y Ono; H Onda; R Sasada; K Igarashi; Y Sugino; K Nishioka
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

10.  Detection of an element of the SV40 late promoter in vectors used for expression studies in COS cells.

Authors:  R Cattaneo; H Will; G Darai; E Pfaff; H Schaller
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  22 in total

1.  Evidence that less-than-full-length pol gene products are functional in hepadnavirus DNA synthesis.

Authors:  T T Wu; L D Condreay; L Coates; C Aldrich; W Mason
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Infection initiated by the RNA pregenome of a DNA virus.

Authors:  M J Huang; J Summers
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted.

Authors:  M Melegari; P P Scaglioni; J R Wands
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA.

Authors:  P Soussan; F Garreau; H Zylberberg; C Ferray; C Brechot; D Kremsdorf
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

5.  Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165-173).

Authors:  Sophie Le Pogam; Pong Kian Chua; Margaret Newman; Chiaho Shih
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  The hepatitis B virus posttranscriptional regulatory element is composed of two subelements.

Authors:  J E Donello; A A Beeche; G J Smith; G R Lucero; T J Hope
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Hepatitis B virus DNA splicing in Lebanese blood donors and genotype A to E strains: implications for hepatitis B virus DNA quantification and infectivity.

Authors:  Mira El Chaar; Tamima El Jisr; Jean-Pierre Allain
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

8.  Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.

Authors:  Kuen-Nan Tsai; Chin-Liew Chong; Yu-Chi Chou; Chien-Chiao Huang; Yi-Ling Wang; Shao-Win Wang; Mong-Liang Chen; Chun-Hong Chen; Chungming Chang
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

9.  Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm.

Authors:  Z M Huang; T S Yen
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo.

Authors:  S Terré; M A Petit; C Bréchot
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.